Skip to main content
    E

    Enovis Corp (ENOV)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NYSE

    $27.20
    -0.72 (-2.58%)

    Market Cap: $1.60B

    Last updated: Nov 17, 2026 at 4:20 PM ET

    Enovis Corp (ENOV) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Enovis (ENOV) has a latest price of $27.20 on Nov 17, 2026, 14.1% below its 52-week high of $31.67. Its price fell 9.3% over the past 12 months. The month-end price fell 63.6% over the 10 years through Oct 2026, a compound annual decline of 9.6%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $88.85 in Oct 2021 and its lowest $18.27 in Sep 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart ENOV with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for ENOV.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price rose 2.6%, and over 6 months it rose 5.6%. The month-end price fell 56.6% over the 3 years through Oct 2026, a compound annual decline of 24.3%.

    PeriodChange
    1 month+36.9%
    3 months+2.6%
    6 months+5.6%
    12 months-9.3%
    12 months, with dividends-9.3%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-56.6%-24.3%
    5 years-77.6%-25.9%
    10 years-63.6%-9.6%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2019, when the price rose 74.1%, and its weakest was 2018, when it fell 47.2%.

    YearCloseChange
    2026 through Oct 2026$19.91-25.3%
    2025$26.64-39.3%
    2024$43.88-21.7%
    2023$56.02+4.7%
    2022$53.52-32.4%
    2021$79.12+20.2%
    2020$65.82+5.1%
    2019$62.62+74.1%
    2018$35.97-47.2%
    2017$68.19+10.3%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 30.4% above its 50-day average of $20.85 and 16.8% above its 200-day average of $23.29.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$27.20
    52-week high$31.67-14.1%
    52-week low$16.70+62.9%
    50-day average$20.85+30.4%
    200-day average$23.29+16.8%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 72.7%.

    MeasureValue
    1-year beta0.94
    Largest fall, 1 year-44.5%
    Largest fall, 3 years-72.7%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Valuation

    Enovis traded at 8.1x earnings at the end of 2025, against a 5-year median of 13.7x and a 10-year median of 12.6x.

    ENOV valuation history

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About ENOV

    What is ENOV's 1-year price change?

    Enovis's price fell 9.3% over the past 12 months. With dividends included, the 12-month total return was -9.3%.

    What is ENOV's 5-year price change?

    Enovis's month-end price fell 77.6% over the 5 years through Oct 2026, a compound annual decline of 25.9%. These figures leave out dividends.

    What is ENOV's 52-week high and low?

    Enovis's 52-week high is $31.67 and its 52-week low is $16.70. Its latest price of $27.20 on Nov 17, 2026 is 14.1% below the high.

    What is ENOV's beta?

    Enovis's 1-year beta against the S&P 500 is 0.94, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 44.5%.

    Is the ENOV chart free?

    Yes. Advanced Charting for ENOV is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.